🇺🇸 ARDEPARIN SODIUM in United States

ARDEPARIN SODIUM (ARDEPARIN SODIUM) regulatory status in United States.

Marketing authorisations

FDA

  • Status: approved

FDA

  • Application: NDA020227
  • Marketing authorisation holder: PHARMACIA AND UPJOHN
  • Local brand name: NORMIFLO
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

ARDEPARIN SODIUM in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ARDEPARIN SODIUM approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for ARDEPARIN SODIUM in United States?

Marketing authorisation holder not available in our data.